US FDA declines to approve expanded use of Dynavax's hepatitis B vaccine

Dynavax Technologies

14/05/2024 13:36

May 14 (Reuters) - The U.S. Food and Drug Administration
has declined to approve the expanded use of Dynavax
Technologies'  DVAX.O  hepatitis B vaccine in patients
undergoing hemodialysis, the company said on Tuesday.
    

 (Reporting by Christy Santhosh and Pratik Jain in Bengaluru;
Editing by Tasim Zahid and Shilpi Majumdar)
 ((Christy.Santhosh@thomsonreuters.com;))